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Abstract 41 
 42 
Objective. Despite the potential burden of foot pain, some of the most fundamental 43 
epidemiological questions surrounding the foot remain poorly explored. The prevalence 44 
of foot pain has proved difficult to compare across existing studies due to variations in 45 
case definitions. The objective of this study was to investigate the prevalence of foot 46 
pain in a number of international population-based cohorts usinge original data and to 47 
explore differences in the case definitions used. and create a single harmonised 48 
definition to investigate the prevalence of foot pain in a number of international 49 
population-based cohorts. 50 
Methods. Foot pain variables were examined in five cohorts (the Chingford Women 51 
Study, the Johnston County Osteoarthritis Project, the Framingham Foot Study, the 52 
Clinical Assessment Study of the Foot and the North West Adelaide Health Study). One 53 
foot pain question was chosen from each cohort based on its similarity to the American 54 
College of Rheumatology (ACR) pain question. 55 
Results. The precise definition of foot pain varied between the cohorts. The prevalence 56 
of foot pain ranged from 13 to 36% and was lowest within the cohort that used a case 57 
definition specific to pain, compared to the four remaining cohorts that included 58 
components of pain, aching or stiffness. Foot pain was generally more prevalent in 59 
women, the obese and generally increased with age, being much lower in younger 60 
participants (20-44 years). 61 
Conclusion. Foot pain is common and is associated with female sex, older age and 62 
obesity. The prevalence of foot pain is likely affected by the case definition used, 63 
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therefore consideration must be given for future population studies to use consistent 64 
measures of data collection.  65 
66 
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Significance and Innovations  67 
 68 
 Harmonisation Comparison of original of data is a key component to effectively 69 
enhancing scientific content and value of large studies, both past and current. 70 
This study is the first effort to do so in an under-studied yet common concern in 71 
rheumatology – foot pain 72 
 As seen with data harmonisation of knee outcomes, the prevalence of foot pain 73 
is likely affected by the case definition used 74 
 Rather than using summary estimates of effect in future work, the use of original 75 
participant data across cohorts allows for a more detailed consideration of the 76 
heterogeneity in variable case definitions 77 
 Consideration must be given for future population studies to use more consistent 78 
measures of data collection 79 
 80 
  81 
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Introduction 82 
 83 
Foot pain has been identified as an independent risk factor for locomotor disability [1], 84 
impaired balance [2]  increased risk of falls [3, 4], loss of independence, and reduced quality 85 
of life [5]. It is likely that foot pain contributes a significant burden on both older individuals 86 
and healthcare systems. The literature suggests that foot pain is highly prevalent in the 87 
general population, however prevalence estimates vary between 9% and 30% [6-9]. Foot 88 
problems have been reported to account for up to 8% of a general practitioner’s 89 
musculoskeletal caseload in the UK [10, 11]. 90 
 91 
Despite the potential burden of foot pain, to date, some of the most fundamental 92 
epidemiological questions surrounding the foot remain poorly explored, particularly with 93 
consideration to basic demographic features.  Accurately estimating the burden of foot pain 94 
among the general population is important so that clinical and cost-effective management 95 
strategies can be implemented. Estimating the proportion of a population with a condition 96 
such as foot pain will provide the basis for determining the number of people who may 97 
require care, for monitoring changes in condition occurrence over time, An investigation of 98 
foot pain prevalence using original data in a number of international population-based 99 
cohorts would enable differences in foot pain frequency between across geographical 100 
regions and sociodemographic groups, with consideration of age, sex, body mass index 101 
(BMI) and race to be determined..  Frequencies obtained from research Prevalence 102 
estimates would also provide a foundation to establishing the reasons for differences in 103 
such figuresare the basis for probability estimates for the purposes of patient care and 104 
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future research can begin to establish potential risk factors for foot pain and associated 105 
conditions..  106 
 107 
Traditional meta-analyses can be valuable and efficient in terms of time and resources 108 
required, but can suffer from several substantial limitations. They are limited to published 109 
results and may therefore suffer from publication bias and the quality and availability of 110 
data may vary across studies [12]. Such issues have been previously encountered due to the 111 
considerable variation used in case definitions for type, period and patterns of pain, which 112 
limited the ability to pool data and provide accurate prevalence estimates [7]. The 113 
heterogeneity of variable case definitions is a limitation to any research looking to compare 114 
data across cohorts or study data sets. It is necessary to examine identify the components 115 
and definitions of each variable and where possible produce a method to standardise of 116 
harmonisation for each variable. Such methods have been previously highlighted in the 117 
investigation of knee osteoarthritis (OA) [13, 14].  118 
 119 
Therefore, the primary aim of this study was to identify the prevalence of foot pain in five 120 
prospective cohorts using original participant data. The secondary aim was to consider  and 121 
investigate potential reasons for differences in pain across geographical locations stratified 122 
byaccording to important factors, including such as age, sex, BMI and race, selection bias in 123 
each cohort (sampling method, response rate and loss to follow-up) and measurement bias , 124 
with consideration of (foot pain case definitions). The cross-sectional study makes use of 125 
original data from five international population cohorts linked to a consortium of 126 
international foot collaborators., with the aim to harmonise case definitions of each variable 127 
to create a single standardised definition of foot pain across five cohorts. 128 
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 129 
 130 
Early findings from a cross-cohort foot osteoarthritis collaboration project with principal 131 
investigators from prospective cohorts including the Chingford Women Study, the Johnston 132 
County Osteoarthritis Project and the Framingham Foot Study Chingford Women Study, 133 
revealed a need to establish a larger consortium of foot and ankle collaborators to address 134 
the variations in data collection across population cohorts.  In 2017 a consortium of 135 
international collaborators was formed to encourage a more collaborative approach to foot 136 
and ankle research. The consortium consisted of principle investigators and researchers 137 
associated with current epidemiological foot and ankle cohort studies and representative 138 
research. Potential cohorts for the current study were identified through members of the 139 
consortium with knowledge of prospective population based cohorts rich in foot pain data. 140 
that were not enhanced for risk factors of lower limb musculoskeletal disease. The 141 
Chingford Women Study [15][15][15][15][15][15][15][15][15], the Johnston County 142 
Osteoarthritis Project [16], the Clinical Assessment Study of the Foot 143 
[17][17][17][17][16][16][16][16][16], the Framingham Foot Study [18] and the North West 144 
Adelaide Health Study were identified [19]. 145 
 146 
 147 
Chingford Women Study 148 
 149 
The Chingford Women Study is an ongoing prospective population-based longitudinal 150 
cohort of women, established to assess risk factors and associations with osteoporosis and 151 
OA [15].  The cohort originally consisted of 1003 women aged 45-64 years recruited from a 152 
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general practice in Chingford, North-East London, United Kingdom (UK). Since 1989 the 153 
women have been assessed almost annually with a number of investigations. The current 154 
study used data from year 15 (2003).  155 
 156 
Johnston County Osteoarthritis Project 157 
 158 
The Johnston County Osteoarthritis Project is an ongoing, population-based longitudinal 159 
study, established to investigate the epidemiology of OA among African Americans and 160 
Caucasians residing in six townships in a mostly rural county in North Carolina, United States 161 
of America (USA) [16]. Participants recruited to this study were civilian, non-institutionalized 162 
residents who were at least 45 years old.  The original cohort included participants enrolled 163 
between 1991 and 1997.  Data for the present analysis were from the first follow-up visit 164 
(T1), collected during 1999-2004.  165 
 166 
Clinical Assessment Study of the Foot 167 
 168 
The Clinical Assessment Study of the Foot is an ongoing population-based prospective 169 
observational cohort study of foot pain and foot OA [17]. All adults aged 50 years and over 170 
registered with four general practices in North Staffordshire, UK were invited to take part in 171 
the study, irrespective of consultation for foot pain or problems. The present study uses 172 
data from the initial baseline health survey questionnaire mailed in 2010/2011, which 173 
gathered information on aspects of general health, including foot pain.  174 
 175 
Framingham Foot Study 176 
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 177 
The Framingham Foot Study includes members of the Framingham Heart Study Original 178 
Cohort, the Framingham Heart Study Offspring Cohort, and a third community sample [18]. 179 
The Original Cohort was formed in 1948 from a two-thirds sample of the town of 180 
Framingham, MassachusettsMA, USA in order to study risk factors for heart disease and has 181 
been examined biennially [20]. In 1972, the offspring and spouses of the offspring formed 182 
the Offspring Cohort to study familial risk factors for heart disease and have been examined 183 
every four years [21]. The community sample was derived from census-based, random-digit 184 
dialling within the Framingham community contacting subjects who were >50 years old and 185 
ambulatory in order to increase participation by minorities.  Data for the present analysis 186 
were collected between 2002 and 2008.  187 
 188 
North West Adelaide Health Study 189 
 190 
The North West Adelaide Health Study is a longitudinal study of randomly selected adults 191 
aged 18 years and over at the time of recruitment (1999 to 2003) from the North-West 192 
region of Adelaide, South Australia. It aims to increase the ability of strategies and policies 193 
to prevent, detect and manage a range of chronic conditions [19]. Participant information 194 
was obtained from a Computer Assisted Telephone Interview (CATI), a self-completed 195 
questionnaire and a clinic assessment at each stage [19, 22]. The present study used data 196 
collected in stage 2 (2004-2006). 197 
 198 
Inclusion criteria 199 
 200 
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Across all included cohorts, participants who had responded to the foot pain question were 201 
selected for analysis. Where available, age, sex, BMI and race were also extracted for each 202 
participant. 203 
 204 
Statistical analysis 205 
 206 
Descriptive data for demographic characteristics of each cohort were calculated using 207 
means and standard deviations or frequencies and percentages, as appropriate.  Prevalence 208 
and 95% confidence intervals were also calculated for foot pain by age, sex, BMI and race 209 
for each cohort. Sensitivity analysis was undertaken on The Chingford Women Study to 210 
estimate foot pain prevalence with adjusted cut off points (6+ /15+ days). 211 
 212 
The Chingford Women Study and Johnston County Osteoarthritis project data analyses were 213 
undertaken using Stata version 14.1 at Oxford University. The remaining cohort analyses 214 
were undertaken in-house; Clinical Assessment Study of the Foot using Stata version 14 215 
(Stata Corp, College Station, Texas, USA); Framingham Foot Study using SAS Version 9.4 (SAS 216 
Institute, Cary, NC); North West Adelaide Health Study using SPSS Version 24 (IBM, Armonk, 217 
NY, USA) and STATA 14.2 .  218 
 219 
Ethics 220 
 221 
The Chingford Women Study was approved by the Outer North East London Research Ethics 222 
Committee, and written consent was obtained from each woman. The Johnston County 223 
Osteoarthritis Project was approved by the Institutional Review Boards at the University of 224 
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North Carolina and the Centers for Disease Control and Prevention. Clinical Assessment 225 
Study of the Foot ethical approval was obtained from Coventry Research Ethics Committee 226 
(REC reference number: 10/ H1210/5) and all participants gave their written consent to 227 
participate. The Framingham Foot Study was approved by the Hebrew SeniorLife and Boston 228 
University Medical Center Institutional Review Boards and participants provided written, 229 
informed consent prior to enrolment. North West Adelaide Health Study ethical approval 230 
was obtained from the Human Research Ethics Committee of The Queen Elizabeth Hospital, 231 
Adelaide, South Australia and all participants provided written informed consent. 232 
 233 
Results  234 
  235 
Study population 236 
 237 
A summary of sample characteristics of each cohort is shown in Table 1.  238 
 239 
Response rates and loss to follow-up 240 
 241 
 242 
Chingford Women Study 243 
 244 
Of the original cohort of 1003 participants, 658 (65.6%) returned at year 15 in 2003 and 245 
completed a joint symptom questionnaire. Four (0.6% of year 15) participants were 246 
excluded from the current study due to missing data on foot pain, leaving 655 for analysis. 247 
 248 
Johnston County Osteoarthritis Project 249 
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 250 
Of the original cohort of 3187 participants, 1739 (54.6%) returned for the follow-up clinic 251 
visit (T1) from 1999-2004. One hundred and twenty (6.9% of T1) participants were excluded 252 
from the current study due to missing data either in demographics or foot pain, leaving 253 
1619 for analysis. 254 
 255 
Clinical Assessment Study of the Foot 256 
 257 
The baseline health survey questionnaire was mailed to 9334 adults and completed by 5109 258 
(adjusted response 56%). Of these, 619 (12.1%) participants were excluded from the current 259 
study due to missing data either in the foot pain questions or demographics leaving 4,490 260 
for analysis. 261 
  262 
Framingham Foot Study 263 
 264 
3429 participants were included in the baseline data collection between 2002 and 2008. 265 
Nine (0.3% of participants) were excluded from the current study due to missing data either 266 
in demographics or foot pain, leaving 3420 for analysis.  267 
 268 
North West Adelaide Health Study 269 
 270 
The original cohort of participants was 4056, with 3205 (79.0% of the eligible sample) 271 
participating in all three data collections (the CATI survey, self-complete questionnaire and 272 
clinic assessment) in Stage 2 between 2004 and 2006. Of these 60 (1.9% of stage 2 sample) 273 
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were excluded due to missing data either in the demographics or the foot pain questions, 274 
leaving 3145 for analysis. 275 
 276 
Harmonisation Standardisation of foot pain 277 
 278 
Each cohort was examined for available foot pain questions. Each cohort’s foot pain 279 
questions were assessed for differences in the duration of pain (i.e. any/most days) and the 280 
period of recall (i.e. in the last month/last year/ever). As there was a variation of pain 281 
duration and recall between a number of the cohorts’ questions, oOne foot pain question 282 
was selected from each cohort based on its similarity to the American College of 283 
Rheumatology (ACR) question: “Have you had pain (in either foot) on most days in the last 284 
month?” [13].  Where questions provided categorical answers these were standardised to 285 
provide dichotomous (yes/no) responses.  286 
ach cohort’s foot pain questions were assessed for differences in the duration of pain (i.e. 287 
any/most days) and the period of recall (i.e. in the last month/last year/ever). As there was 288 
a variation of pain duration and recall between a number of the cohorts’ questions, a new 289 
harmonised pain variable was derived based on the common components of all questions; 290 
“Pain in either foot on most days” (table 2). 291 
 292 
The prevalence of foot pain ranged from 13 to 36% between cohorts (see Table 3 for all 293 
stratified foot pain results). Foot pain was more prevalent in women than men across all 294 
cohorts where data on both sexes were available, and the largest absolute difference in the 295 
occurrence of foot pain between men and women was 11% in the Framingham Foot Study. 296 
Prevalence ranged from 9-36% in those aged 55-64, 14-36% aged 65-74 and 15-37% in those 297 
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75 years and older (Figure 1). Foot pain was most prevalent in those classified as obese 298 
(BMI >30.0) in all cohorts (Figure 2). In the Johnston County Osteoarthritis Project, the 299 
Clinical Assessment Study of the Foot and the North West Adelaide Health Study, foot pain 300 
prevalence was also high at a BMI lower than 18.5, however numbers were small with wide 301 
95% confidence intervals. Four cohorts reported race, two of which were limited to only 302 
Caucasian participants (Chingford Women Study and Framingham Foot Study). Prevalence 303 
of foot pain within Caucasian participants ranged from 13-36%. In the Johnston County 304 
Osteoarthritis Project, the frequency of foot pain was comparable in Caucasians and African 305 
Americans (36 and 35%, respectively). Where other races were available within the Clinical 306 
Assessment Study of the Foot, foot pain prevalence was highest amongst Africans at 38% 307 
compared to only 10% in Asian participants, however the number of these participants was 308 
low with wide confidence intervals.  309 
 310 
Figure 1. Prevalence of foot pain across cohorts by age 311 
 312 
Figure 2. Prevalence of foot pain across cohorts by BMI category 313 
 314 
Discussion 315 
 316 
This is the first study to use original data to compare the prevalence of foot pain across 317 
multiple international populations. Foot pain ranged from 13% in the Chingford Women 318 
Study, 18% in the North West Adelaide Health Study, 21% in the Clinical Assessment Study 319 
of the Foot, 25% in the Framingham Foot Study, to 36% in the Johnston County 320 
Osteoarthritis Project.  The study highlights the differences in foot pain across age, sex, BMI 321 
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and race, whilst considering differences in case definitions used for variables, a vital 322 
consideration when combining or comparing data across multiple data sets.  323 
 324 
Where cohorts included both men and women, there was a consistently higher prevalence 325 
of foot pain in women. This difference has been widely reported [6, 7, 9, 23], with a 326 
suggested partial attribution to lifetime footwear habits, although other factors such as 327 
occupation and family history are also thought to contribute [18, 24]. Women are more 328 
likely to report musculoskeletal pain in general and consideration should also be given to 329 
sex-related variations in pain perception [25] hormonal influences [26], and psychological 330 
and social factors [27]. However, the role of other potential sex differences such as 331 
occupation or physical activity levels is currently unknown. The overall prevalence of foot 332 
pain was actually lowest within the Chingford Women Study, the women-only cohort. Whilst 333 
unknown factors such as comorbidities may play a role, this is likely due to the case 334 
definition used for foot pain. In the Chingford Women Study the question was specific to 335 
pain only, in comparison to all other cohorts whose question included pain, aching and 336 
stiffness. This challenges whether the use of  pain questions including aching and stiffness 337 
may overestimate pain.  The original foot pain question in Chingford Women Study allowed 338 
for a categorical response of 0, 1-5, 6-14 and 15+ days. For the purposes of harmonisation 339 
standardising with the remaining four cohorts in this study, which all used a foot pain 340 
duration of “most days”, a cut off of 15+ days was chosen to represent most days in the 341 
Chingford Women Study. This cut point was identical to that used in a previous study to 342 
represent painful knee osteoarthritis [28]. However, because no explicit number of days was 343 
provided to Chingford participants to represent “most” days, it cannot be assumed that all 344 
participants would classify 15+ days as most days. A sensitivity analysis was therefore 345 
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undertaken to estimate foot pain prevalence with an adjusted cut off point of 6+ days, to 346 
capture participants who answered 6-14 days. Foot pain prevalence rose from 12.5% (15+ 347 
days) to 18% (6+ days), thus highlighting the sensitivity in prevalence estimates according to 348 
the question response components.  349 
 350 
The prevalence of foot pain generally increased with age and was much lower in younger 351 
participants (20-44 years) compared to those over the age of 45 years. This increase is in 352 
concordance with previous studies [7, 29]. Although small differences in foot pain 353 
prevalence can be seen by decade above the age of 45, overlapping 95% confidence 354 
intervals suggest there is little difference in these prevalence estimates. Results of a 355 
systematic review and a survey study found a stronger positive association of foot pain with 356 
age among women than men [7, 9]. This may is likely in part be  due to thegender 357 
differences in pain perception, where women are known to report more severe levels of 358 
pain, more frequent pain and pain of longer duration than do men [25, 27]. Also the higher 359 
frequency of pain-related conditions  such as osteoarthritis, which are seen more commonly 360 
in women and older persons [30]. and suggests that women of older age are more likely to 361 
report foot pain. 362 
 363 
In all cohorts, the prevalence of foot pain was highest in those classified as obese. Foot pain 364 
was more prevalent at the lower and upper extremes of BMI in the Johnston County 365 
Osteoarthritis Project, the Clinical Assessment Study of the Foot and the North West 366 
Adelaide Health Study, however small participant numbers and wide 95% confidence 367 
intervals in the low BMI category (<18.5) suggest these estimates should be interpreted with 368 
caution. Foot pain prevalence showed an incremental increase with BMI in the Framingham 369 
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Foot Study. Previous cross-sectional studies have also reported associations between 370 
increasing BMI and foot pain  [31, 32], in particular fat mass [31, 33]. There is also evidence 371 
from longitudinal studies that BMI is a predictor of incident foot pain over 5 years [34] and 372 
fat mass is a predictor of incident foot pain over 3 years [35].  373 
 374 
Race data were largely limited to the Caucasian demographic, with foot pain prevalence 375 
lower in both UK cohorts than the USA. In the bi-racial cohort of the Johnston County 376 
Osteoarthritis Project, the occurrence of foot pain was similar between Caucasians and 377 
African Americans. In the Clinical Assessment Study of the Foot, foot pain prevalence was 378 
highest in Africans, then Afro Caribbean and Caucasians of similar prevalence, and lowest in 379 
Asians, but interpretation of these findings is limited because only 2% of the sample were 380 
racial/ethnic minorities (not Caucasian). Previous studies found significant racial/ethnic 381 
differences in the prevalence of common foot disorders, independent of sex or education. 382 
Two previous studies, using data not included within the current study also found 383 
differences in between races. In the Feet First study, USA, the total number of foot 384 
conditions such as toe deformities, flat feet, corns, calluses and skin pathologies, and ankle 385 
joint pain were found to be more prevalent in African Americans than in non-Hispanic 386 
Whites and in Puerto Ricans [36]. In the Women's Health and Aging Study, USA, significant 387 
differences in pain severity were found between races, with more foot pain found in black 388 
than non-black participants [37].  389 
 390 
It has been suggested that the differences in health conditions between racial and ethnic 391 
groups could be due to different levels of access to health care, different rates of chronic 392 
conditions (such as diabetes, obesity, or vascular disease) possibly associated with foot 393 
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ailments, early life experiences, or occupational patterns that differ among groups 394 
independently of education [36]. As ethnicity is the term given for the culture of people in a 395 
given geographical region, including but not limited to language, religion and customs, it 396 
would be beneficial to consider the role of ethnicity in the investigation of pain and/or 397 
conditions. Further work is required to determine the etiologic factors for such differences. 398 
 399 
The strengths of this study are that results are generalizable to first world populations, as 400 
data were sourced from population-based prospective observational cohorts at a time point 401 
where no enhancement was made for known risk factors, therefore reducing the chance of 402 
selection bias. This study analysed original cohort data and was therefore not limited to 403 
previously published data. Whilst most studies within standard meta-analysis use a variety 404 
of definitions of outcomes, the current study was able to minimise this variation by choosing 405 
similar questions at selected time points. This approach can be expanded to other time 406 
points and for other variables to enable longitudinal individual participant data meta-407 
analysis to identify risk factors for foot pain and associated conditions. Although the 408 
wording of pain questions differed for two of the cohorts, all five cohorts used questions 409 
that were specific to self-reported foot pain. 410 
The biggest challenge when comparing data across population cohorts is the heterogeneity 411 
that exists across factors such as recruitment methods, data collection time points and 412 
variable definitions. Even when comparable variable definitions are used, there is often 413 
further heterogeneity within the measures used to collect data and the parameters of each 414 
variable. The main limitation found from this study was the variation in questions used to 415 
determine the presence of foot pain, particularly the duration of pain and the question 416 
response components, as shown from the response categories in the original pain questions 417 
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in the Chingford Women Study.  A recent study has shown that the variation of wording in 418 
NHANES type pain questions can result in varying knee pain prevalence between 41% and 419 
75% [13]. Although the NHANEs type questions were designed to capture joint pain related 420 
to OA, we cannot confidently confirm the cause of foot pain in all participants. 421 
 422 
The Chingford Women Study and the Framingham Foot Study are predominantly Caucasian, 423 
therefore results cannot be generalised to other races. Similarly, the Chingford Women 424 
Study is a woman-only cohort. Country of birth, but not race, was collected in the North 425 
West Adelaide Health Study. Those born in Australia were asked if they are Aboriginal or 426 
Torres Strait Islander (ATSI), however there were only 11 people who identified as ATSI in 427 
stage 2. Country of birth does not represent the race categories used in the remaining four 428 
cohorts. The North West Adelaide Health Study has a predominantly Caucasian sample and 429 
thus country of birth was not included in the analysis.  430 
 431 
Johnston County, North Carolina is a lower‐income, semirural area in the southern US that 432 
includes a greater proportion of lower income residents than observed in the populations 433 
from which other cohorts in the present study were derived [38]. An inverse relationship 434 
between Foot pain frequency estimates for the Johnston County Osteoarthritis Project may be higher 435 
than other cohorts because lower socioeconomic status andis associated with greater the 436 
prevalence of musculoskeletal pain has been previously shown in adults [39, 40], this must herefore be taken into account for the potential generalisabilty of oot pain prevalence estimates for the Johnston County Osteoarthrits Project. We do expect hat foot pain 437 
prevalence is likely high in the US, given that the cohort from Framingham, Massachusetts 438 
presents the second highest foot pain prevalence across these cohorts. Also, high BMI, 439 
which is also a potentially important factor associated with foot pain [34], is highestmore common in the Johnston 440 
County Osteoarthritis Project participants than in other cohorts. 441 
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 442 
Year 15 follow up was chosen in the Chingford Women Study due to the availability of a foot 443 
pain question at this time point. The inability to use baseline data resulted in a smaller 444 
sample than the original baseline. Those who did not attend year 15 tended to be older with 445 
a higher BMI at baseline compared to year 15 attendees who were selected for this study. 446 
For the Clinical Assessment Study of the Foot, response to the baseline health questionnaire 447 
was lower than expected (56%). However, responders did not differ greatly from the mailed 448 
population by age, sex or general practice [41]. For the Johnston County Osteoarthritis 449 
Project, generally persons who did not return for T1 tended to be older, less educated and 450 
more likely to be male and African American. For the North West Adelaide Health Study 451 
Stage 2 data collection was used for foot pain as this was the first time musculoskeletal 452 
questions were asked of the cohort. Participants who failed to provide information at stage 453 
2 tended to be younger, with a slightly higher number of men than women.  454 
 455 
The strengths of this study are that the results are based on data sourced from population-456 
based prospective observational cohorts, therefore enhancing generalisability and reducing 457 
the chance of selection bias. This study analysed original participant data and was therefore 458 
not limited to the publication bias inherent with analysing previously published results. 459 
Whilst most studies within standard meta-analysis use a variety of definitions of outcomes, 460 
the current study was able to minimise this variation by choosing similar questions at 461 
selected time points. This approach can be expanded to other time points and for other 462 
variables to enable longitudinal individual participant data meta-analysis to identify risk 463 
factors for foot pain and associated conditions. Although the wording of pain questions 464 
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differed for two of the cohorts, all five cohorts used questions that were specific to self-465 
reported foot pain. 466 
 467 
This study provides useful comparisons of foot pain between five population cohorts. 468 
Comparisons show that irrespective of geographical location, the prevalence of foot pain is 469 
higher among those who are obese and lower in younger participants (20-44 years). 470 
Although lower in the younger population, it is important to recognise that foot pain does 471 
occur in this age-group and may warrant further investigation and clinical attention. 472 
Between-cohort data for race were limited, however within-cohort results showed foot pain 473 
was potentially more prevalent in African participants. Foot pain was also more prevalent in 474 
women than men.  475 
 476 
This study has highlighted variation in how pain data is collected between cohorts. A degree 477 
of the variation in prevalence between cohorts may, at least in part, be due to the sensitivity 478 
of different pain definitions. In particular, it is important to consider the effect that including 479 
all the components of pain, aching or stiffness in one question may have on estimating the 480 
prevalence of pain only. Future population studies should use more consistent measures of 481 
data collection and the role of question response categories should not be underestimated. 482 
Agreement on a standardised set of key foot questions and measures would be useful for 483 
future prospective data collection phases within existing and newly establishing cohorts. 484 
 485 
 486 
  487 
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Table 1. Demographic characteristics of each cohort 
  Chingford 
Women 
Johnston County 
Osteoarthritis 
Project 
Framingham 
Foot Study 
Clinical 
Assessment 
Study of the 
Foot   
North West 
Adelaide Health 
Study  
Data 
collection 
time point 
 Year 15 
(2003) 
T1 (1999-2004) Phase 1 (2002 
and 2008) 
Respondents to 
baseline health 
survey  
(2010-2011) 
Participants at 
stage 2 clinic 
(2004–2006) 
n (at time 
point) 
 655 1619 3420 4490 3145 
Age, M (± SD 
y) 
 68.6 (5.8) 65.8 (9.8) 66.5 (10.6) 64.9 (9.8) 47.6 (17.5) 
Age 
category, n 
(%) 
20–34 - - - - 889 (28.3) 
35–44 - - 17 (0.5) - 644 (20.5) 
45–54 - 203 (12.5) 451 (13.2) 741 (16.5) 557 (17.7) 
55–64 206 (31.5) 592 (36.6) 1208 (35.3) 1624 (36.2) 428 (13.6) 
65–74 308 (47.0) 484  (29.9) 944 (27.6) 1334 (29.7) 320 (10.2) 
≥75 141 (21.5) 340  (21.0) 800 (23.4) 791 (17.6) 307 (9.8) 
Sex  Men, n (%) - 581 (35.9) 1499 (43.8) 2198 (49.0) 
 
1545 (49.1) 
Women, n 
(%) 
655 (100.0) 1038 (64.1) 1921 (56.2) 2292 (51.0) 1600 (50.9) 
Body mass 
index, M ± 
SD kg/m2  
 27.2 (4.8) 30.2 (6.3) 28.4 (5.5) 27.5 (5.2) 27.8 (5.7) 
Body mass 
index 
category, n 
(%)  
<18.5 10 (1.5) 13 (0.8) 23 (0.7) 62 (1.4) 43 (1.4) 
18.5–24.9 228 (34.8) 290 (17.9) 937 (27.4) 1480 (33.0) 1014 (32.2) 
25.0–29.9 241 (36.8) 588 (36.3) 1335 (39.0) 1808 (40.3) 1169 (37.2) 
≥30.0 176 (26.9) 728 (45.0) 1125 (32.9) 1140 (25.4) 919 (29.2) 
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Race 
 
 
Caucasian, n 
(%) 
655 (100.0) 1158 (71.5) 3420 (100.0) 4395 (97.9) 
  
- 
African 
American, n 
(%) 
 461 (28.5) - - - 
Afro 
Caribbean, n 
(%) 
 - - 14 (0.3)   - 
Asian, n (%)  - - 49 (1.1) - 
African, n 
(%) 
 - - 8 (0.2) - 
Other, n (%)  - - 24 (0.5)   - 
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Table 2. Harmonisation of foot pain variable across cohorts 
Cohort Original Question 
Transformed Responses standardised to match 
“pain on most day” variable 
Chingford Women 
Study 
 
“On how many days§ in the last 
month* did you get pain?” 
(0/1-5/6-14/15+ days) § 
Pain in either foot on most days (L/R) 
1. Pain on most days (yes)= pain on at least 15 
days 
2. Pain on most days (no) = pain on less than 15 
days  
 
Johnston County 
Osteoarthritis Project 
 
“On most days§ do you have 
pain, aching or stiffness in your 
feet?” 
(Yes/No) 
Pain in either foot on most days (L/R) 
1. Yes 
2. No 
Framingham Foot 
Study 
“On most days§ do you have 
pain, aching or stiffness in your 
feet?” 
(Yes/No) 
Pain in either foot on most days (L/R) 
1. Yes 
2. No 
Clinical Assessment 
Study of the Foot 
“Pain, aching or stiffness in the 
foot in the past month*” 
(No days/Few days/Some 
days/Most days/All days)§  
Pain in either foot on most days (L/R) 
1. Pain on most days (yes)= Most days/All days & 
had foot pain in the last year 
2. Pain on most days (no) = No days/Few 
days/Some days & had foot pain in the last 
year OR did not have foot pain in the last year 
 
North West Adelaide 
Health Study 
“On most days§, do you have 
pain, aching or stiffness in 
either of your feet?" 
(Yes/No) 
Pain in either foot on most days (L/R) 
1. Yes 
2. No 
*Period of recall for foot pain    §Duration of foot pain 
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Table 3. Prevalence of foot pain stratified by age, sex, body mass index (BMI) and race 
 
  
Chingford 
1000 
Women 
Johnston County 
Osteoarthritis 
Project 
Framingham 
Foot Study 
Clinical 
Assessment 
Study of the 
Foot  
North West 
Adelaide 
Health 
Study 
 
 
N=665 N=1619 N=3420 N=4490 N=555 
Foot pain % 
(95% CI) 
 
12.5 (10.2, 
15.3)  
36.0 (33.7, 38.4) 25.0 (23.5, 26.4) 20.6 (19.5, 21.8) 
17.7 (16.0-
19.4) 
Age % (95% 
CI) 
20–34 
 
- - - 
10.5 (7.0-
15.4) 
35–44 
 
- 11.8 (0.0, 28.8) - 
10.8 (8.4-
13.8) 
45–54 
 
34.5 (28.2, 41.3) 28.2 (24.0, 32.3) 19.6 (16.9, 22.6) 
21.8 (18.5-
25.4) 
55–64 
9.2 (5.9, 
14.1) 
36.0 (32.2, 39.9) 26.6 (24.1, 29.1) 20.5 (18.6, 22.5) 
24.2 (20.8-
28.0) 
65–74 
13.6 (10.2, 
18.0) 
35.7 (31.6, 40.1) 22.4 (19.7, 25.0) 20.3 (18.2, 22.6) 
26.4 (22.5-
30.8) 
75≥ 
14.9 (9.9, 
21.9) 
37.4 (32.4, 42.7) 24.1 (21.2, 27.1) 22.4 (19.6, 25.4) 
27.0 (22.4-
32.2) 
Sex % (95% 
CI) 
Men 
 
30.5 (26.9, 34.3) 19.0 (17.0, 21.0) 18.3 (16.7, 20.0) 
15.3 (13.2-
17.7) 
Women 
12.5 (10.2, 
15.3) 
39.1 (36.2, 42.1) 29.6 (27.6, 31.7) 22.9 (21.2, 24.6) 
19.9 (17.5-
22.5) 
BMI 
(kg/m2) % 
(95% CI) 
<18.5 
10.0 (0.8, 
57.8) 
38.5 (14.6, 69.5) 17.4 (0.6, 34.2) 22.6 (13.7, 35.0) 
22.3 (6.4-
54.8) 
18.5 – 24.9 
11.4 (7.9, 
16.3) 
26.6 (21.8, 32.0) 20.7 (18.1, 23.3) 14.4 (12.7, 16.3) 
10.8 (8.7-
13.2) 
25.0 – 29.9 
10.0 (6.7, 
14.5) 
31.0 (27.3, 34.8) 22.8 (20.5, 25.0)  19.1 (17.4, 21.0) 
17.6 (15.3-
20.2) 
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30.0≥ 
17.6 (12.6, 
24.0) 
43.8 (40.2, 47.5) 31.3 (28.6, 34.0) 31.0 (28.3, 33.7) 
25.1 (21.6-
29.0) 
Race  % 
(95% CI) 
Caucasian  
12.5 (10.2, 
15.3) 
36.4 (33.7, 39.3) 25.0 (23.5, 26.4) 20.8 (19.6, 22.0) - 
African 
American 
- 34.9 (30.7, 39.4) - - - 
Afro 
Caribbean 
- - - 21.4 (6.0, 54.0) - 
Asian - - - 10.2 (4.2, 22.9) - 
African - - - 37.5 (8.7, 79.2) - 
Other  - - - 12.5 (3.7, 34.5) - 
